Study of tests for tracking vision in retinal disease
Part of Eyes & vision, Genetic & congenital clinical trials.
This study will check if certain vision tests work well in people with retinal diseases like retinitis pigmentosa or Stargardt. Results will help design future trials.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a retinal disease such as retinitis pigmentosa or Stargardt disease in both eyes.
- Your vision in at least one eye is between 20/70 and hand motion (seeing only hand movement).
- You can read and speak English comfortably.
- You do not have serious memory loss or dementia that would make it hard to follow instructions.
- You are not pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is looking at how people with inherited retinal disease that affects peripheral vision see and move around. It will test a new way to measure vision and navigation to see if it can help doctors understand how the disease affects daily life.
This study follows people with Stargardt disease (a genetic eye condition that causes vision loss) over time. It aims to learn more about how the disease progresses and does not test any treatment.
This trial tests a single injection of a new medicine, RTx-021, into the eye for people with Stargardt disease. The goal is to see if it is safe and to find the right dose.
This study tests a new way to measure vision, called MLSDT, in people with normal sight or vision loss from Stargardt disease or geographic atrophy (a type of advanced age-related macular degeneration). Results will help doctors better understand how well patients can see.
This study measures how your eyes use two types of light-sensing cells (rods for dim light and cones for clearer detail). It may help researchers better understand retinal (retina) diseases and how well vision is functioning.
This study is for people with inherited retinal diseases. Researchers want to learn how the disease changes over time and how specific gene changes affect vision. You will have eye exams and imaging to track your condition.
Hear when a new Retinitis Pigmentosa trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.